California Court Deals Setback To Sanofi In Lovenox Patent Trial

Law360, New York (June 17, 2005, 12:00 AM EDT) -- In a setback for French drug maker Sanofi-Aventis SA, a California federal court has granted a motion for summary judgment for inequitable conduct in a patent dispute with generics makers Amphastar and Teva Pharmaceuticals USA over the anti-thrombotic medication Lovenox.

A formal entry of the ruling as a final judgment of the court would result in the lifting of the 30-month stay on U.S. Food and Drug Administration approval which has been in place since the initiation of this patent infringement suit, Sanofi said.

“While Amphastar...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.